The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A history of intragastric balloons
Abstract
The history of intragastric balloons (IGBs) began in 1985 with the Garren-Edwards Bubble. It was approved by the U.S. Food and Drug Administration (FDA) for temporary use as a weight loss device, but its manufacture was discontinued in 1988, and approval was withdrawn in 1992 because of significant complications and limited and recidivistic weight loss. A number of IGBs have appeared since that time, mostly originating in Europe or South America, but none has acquired FDA approval until recently; the ReShape Duo Integrated Dual Balloon System (ReShape Medical Inc., San Clemente, California) received FDA approval in August 2015. The conclusions of an important 1987 international conference on IGBs and the characteristics, effectiveness, and problems of most other IGBs are described in this text. The common purpose of these devices as preliminary interventions before gastric bariatric surgery and their favorable effects on this purpose are emphasized and may have played a key role in the FDA's change of outlook of the IGB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initially introduced in 1984, the first FDA-approved balloon, the Garren-Edwards Gastric Bubble (GEGB), was discontinued after seven years due to significant adverse effects, including gastric erosion, ulcers, small bowel obstruction, and inadequate weight reduction [68,69].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [68]
In the citing paper
“APRI scores improved with EndoBarrier (45–55%) [102], POSE (31%) [68], and IGB (37.8%) [73].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [68]
Citations
Cites
Payne, J. H., & DeWind, L. T. (1969) · The American Journal of Surgery · doi:10.1016/0002-9610(69)90113-5 · Cited by 541
A Prospective Comparison of Gastric and Jejunoileal Bypass Procedures for Morbid Obesity
Griffen, W. O., Young, V. L., & Stevenson, C. C. (1977) · Annals of Surgery · doi:10.1097/00000658-197710000-00012 · Cited by 494
Biliopancreatic diversion for obesity at eighteen years
Scopinaro, N., Gianetta, E., Adami, G., Friedman, D., Traverso, E., Marinari, G. M., Cuneo, S., Vitale, B., Ballari, F., Colombini, M., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80111-5 · Cited by 390
Bioenterics intragastric balloon: the Italian experience with 2,515 patients
Genco, A., Bruni, T., Doldi, S. B., Forestieri, P., Marino, M., Busetto, L., Giardiello, C., Angrisani, L., Pecchioli, L., Stornelli, P., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002202 · Cited by 361
Ponce, J., Woodman, G., Swain, J., Wilson, E., English, W., Ikramuddin, S., Bour, E., Edmundowicz, S., Snyder, B., Soto, F., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.006 · Cited by 279
Outcomes of Preoperative Weight Loss in High-Risk Patients Undergoing Gastric Bypass Surgery
Still, C. D. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.10.994 · Cited by 188
Brazilian Multicenter Study of the Intragastric Balloon
Sallet, J. A. A. S., Marchesini, J. B., Paiva, D. S., Komoto, K., Pizani, C., Ribeiro, M. L. B., MIGUEL, P., Ferraz, Á. A. B., & Sallet, P. C. (2004) · Obesity Surgery · doi:10.1381/0960892041719671 · Cited by 186
Mion, F., Napoléon, B., Roman, S., Malvoisin, E., Trepo, F., Pujol, B., Lefort, C., & Bory, R.-M. (2005) · Obesity Surgery · doi:10.1381/0960892053723411 · Cited by 145
What Becomes of Patients One Year after the Intragastric Balloon has been Removed?
Herve, J., Wahlen, C., Schaeken, A., Dallemagne, B., Dewandre, J.-M., Markiewicz, S., Monami, B., Weerts, J., & Jehaes, C. (2005) · Obesity Surgery · doi:10.1381/0960892054222894 · Cited by 132
Two years of clinical experience with biliopancreatic bypass for obesity
Scopinaro, N., Gianetta, E., Civalleri, D., Bonalumi, U., & Bachi, V. (1980) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.2.506 · Cited by 122
Research works printed but not linked: 1
- National Bariatric Surgery Registry. NBSR Newsletter 1986;1:6.
Cited by
Current status of intragastric balloon for obesity treatment
Kim, S. H., Chun, H. J., Choi, H. S., Kim, E. S., Keum, B., & Jeen, Y. T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i24.5495 · Cited by 148
Recent advances in bariatric surgery: a narrative review of weight loss procedures
Aderinto, N., Olatunji, G. D., Kokori, E., Olaniyi, P., Isarinade, D. T., & Yusuf, I. A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001472 · Cited by 129
Surgical management of obesity
Nudel, J., & Sanchez, V. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.12.002 · Cited by 69
Six intragastric balloons: Which to choose?
Stavrou, G., Shrewsbury, A. D., & Kotzampassi, K. E. (2021) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v13.i8.238 · Cited by 58
New Era: Endoscopic treatment options in obesity—a paradigm shift
Glass, J., Chaudhry, A., Zeeshan, M., & Ramzan, Z. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i32.4567 · Cited by 51
Metadata
- Authors
- Gleysteen, J. J.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Gleysteen, John J.
- Venue
- Surgery for Obesity and Related Diseases
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 12
- Issue
- 2
- Pages
- 430-435
- ISSN
- 1550-7289 (ISSN-L)
- OpenAlex
- W2186040095
- Cited by
- 113
- References
- 33
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 5 · 2023: 15 · 2022: 12 · 2021: 13 · 2020: 15 · 2019: 8 · 2018: 14 · 2017: 12 · 2016: 3
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Surgery for Obesity and Related Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- intragastric balloon
- MeSH terms
- Humans, Obesity, Morbid, Weight Loss, Gastric Balloon, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
